Načítá se...
Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
PURPOSE: Efficacy, tolerability and safety of the novel preservative-free prostaglandin tafluprost 0.0015% were investigated for the treatment of patients with glaucoma or ocular hypertension in a clinical setting. PATIENTS AND METHODS: Data were collected in a non-interventional, prospective, multi...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3104790/ https://ncbi.nlm.nih.gov/pubmed/21629567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S17876 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|